BRPI0923273A2 - Agente anitumor e métodos para sua produção e estabilização - Google Patents

Agente anitumor e métodos para sua produção e estabilização

Info

Publication number
BRPI0923273A2
BRPI0923273A2 BRPI0923273-7A2A BRPI0923273A BRPI0923273A2 BR PI0923273 A2 BRPI0923273 A2 BR PI0923273A2 BR PI0923273 A BRPI0923273 A BR PI0923273A BR PI0923273 A2 BRPI0923273 A2 BR PI0923273A2
Authority
BR
Brazil
Prior art keywords
anitumor
stabilization
agent
production
methods
Prior art date
Application number
BRPI0923273-7A2A
Other languages
English (en)
Inventor
Ilima Iliodorovna Volchenskova
Nadezhda Nikolaevna Maydanevich
Original Assignee
Sokyrko Oleg Sergeevich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAA200906849A external-priority patent/UA90233C2/uk
Application filed by Sokyrko Oleg Sergeevich filed Critical Sokyrko Oleg Sergeevich
Publication of BRPI0923273A2 publication Critical patent/BRPI0923273A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0923273-7A2A 2008-12-22 2009-11-23 Agente anitumor e métodos para sua produção e estabilização BRPI0923273A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
UA200814666 2008-12-22
UAA200906849A UA90233C2 (uk) 2009-06-30 2009-06-30 Спосіб стабілізації протипухлинних засобів на основі водного розчину сполуки платини з дезоксирибонуклеїновою кислотою
PCT/UA2009/000058 WO2010074662A1 (ru) 2008-12-22 2009-11-23 Противоопухолевое средство, способ его получения и способ его стабилизации

Publications (1)

Publication Number Publication Date
BRPI0923273A2 true BRPI0923273A2 (pt) 2014-01-28

Family

ID=42288021

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923273-7A2A BRPI0923273A2 (pt) 2008-12-22 2009-11-23 Agente anitumor e métodos para sua produção e estabilização

Country Status (8)

Country Link
CN (1) CN102227222B (pt)
BG (1) BG66625B1 (pt)
BR (1) BRPI0923273A2 (pt)
EA (1) EA201100618A1 (pt)
IL (1) IL213446A (pt)
PL (1) PL219734B1 (pt)
TR (1) TR201104008T1 (pt)
WO (1) WO2010074662A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102784098A (zh) * 2011-05-20 2012-11-21 湖南省湘中制药有限公司 丙戊酸镁注射液及其制备工艺
JP6286447B2 (ja) * 2013-01-04 2018-02-28 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム シトラートを含む組成物およびその適用
CN104027301B (zh) * 2013-03-05 2017-05-10 肖云彩 一种奥拉西坦组合物注射液
RU2667128C2 (ru) 2016-12-29 2018-09-14 Герман Петрович Беккер Композиция для приготовления противоопухолевого средства и способ приготовления противоопухолевого средства на ее основе

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534513A (en) * 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
UA70455A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Antineoplastic platinum drug for topical treatmentantineoplastic platinum drug for topical treatment of oropharyngeal cancer and method for its usage of oropharyngeal cancer and method for its usage
UA70456A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Dosage form of infusional antineoplastic drug and dosage form of infusional antineoplastic drug and method for its production method for its production

Also Published As

Publication number Publication date
EA015680B1 (ru) 2011-10-31
WO2010074662A1 (ru) 2010-07-01
IL213446A (en) 2013-11-28
IL213446A0 (en) 2011-07-31
PL394863A1 (pl) 2011-09-26
TR201104008T1 (tr) 2011-10-21
EA201100618A1 (ru) 2011-10-31
CN102227222B (zh) 2012-11-21
BG110926A (bg) 2011-10-31
PL219734B1 (pl) 2015-07-31
CN102227222A (zh) 2011-10-26
BG66625B1 (bg) 2017-12-15

Similar Documents

Publication Publication Date Title
BR112012015322A2 (pt) propante e método para formar o propante
BRPI0915481A2 (pt) material e método para produzir o mesmo
BRPI0913074A2 (pt) pneumático e método para sua fabricação
BRPI0821648A2 (pt) Método e dispositivo para pó desagregante
BR112012000882A2 (pt) Preparação cosmética capilar e método para aplicação.
BRPI0916670A2 (pt) estações ponderadas de isca para roedor e métodos relacionados
BRPI0907183A2 (pt) Método e entidade para encriptação simétrica probabilítica
DK2544719T3 (da) Cd37-bindingsmolekyler og immunkonjugater deraf
BRPI0919575A2 (pt) método, e, composição
BRPI0923702A2 (pt) composições de inseticida estáveis e métodos para produzir as mesmas
BRPI0923798A2 (pt) Métodos para produzir um éster e para produzir amidas.
BRPI0923801A2 (pt) Métodos para produzir um éster, e para produzir amidas.
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI1012525A2 (pt) composições de nanopatículas isentas de príons e métodos para sua fabricação
BRPI0916593A2 (pt) processo para modificação contínua de gesso diidratado e gesso diidratado modificado obtido através do processo.
BRPI0916152A2 (pt) aparelho para via aérea melhorado
BRPI0915376A2 (pt) poliésteres espumados e métodos para sua produção
BRPI0919199A2 (pt) suspensões farmacêuticas submicrométricas estabilizadas e métodos para preparas as mesmas
BRPI0821145A2 (pt) Agente terapêutico para prurido
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
BR112012005247A2 (pt) agente antifitoviral
BRPI0823277A2 (pt) Composição, e , método
BRPI0916787A2 (pt) artigo, e, método para fabricar um artigo
BRPI0918294A2 (pt) dispositivo e método para produzir explosões
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 4A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2263 DE 20/05/2014.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AOS DESPACHOS 8.6 E 8.11 PUBLICADOS NA RPI 2263 DE 20/05/2014 E RPI 2278 DE 02/09/2014 RESPECTIVAMENTE.

B65X Notification of requirement for priority examination of patent application
B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2541 DE 17-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.